Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

PLRX — Pliant Therapeutics, Inc. Dilution Risk Tracker

Track PLRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLRX — Get alerts when the score changes →

As of October 13, 2026, Pliant Therapeutics, Inc. (PLRX) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Pliant Therapeutics, Inc. has a market capitalization of $61.05M, 61.92M shares outstanding, 93 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 21%
🔄 Reverse Split model est. 30%
• 50-day avg $1.25 approaching $1 threshold
💰 Capital Raise model 20%
• Active shelf registration ($300M, 491% of market cap)
🔔 Track PLRX — Get forecast alerts →

Market Data

Market Cap$61.05M
Shares Outstanding61.92M
Float60.23M
Cash$158.10M
Debt$28.78M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding61.92MVerified float table or market cache
Public Float60.23MVerified float table or market cache
Market Cap$61.05MMarket data cache
Cash Runway14.7 monthsDilutionWatch score inputs
Shelf Capacity$300.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 8-K 1, EFFECT 1, S-3 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 20.4% shares (2026Q1 vs prior)
93 institutional holders · 61.52M shares
#1 TANG CAPITAL MANAGEMENT LLC 6.14M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.69M shares
#3 MORGAN STANLEY 4.56M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.25M
Days to Cover11.4
% of Float7.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-03-01
EFFECT EFFECT 2026-04-06
S-3 SHELF 2026-03-30
8-K 8K EVENT 2026-03-30
4 INSIDER TRANSACTION 2026-01-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PLRX Dilution Snapshot

Pliant Therapeutics, Inc. (PLRX) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PLRX's DilutionScore has held steady at 50/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202650/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PLRX shares outstanding have decreased 0.0% from 61.45M (Mar 2026) to 61.45M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 17, 202661.45M60.23M▲ 0.02%
Mar 15, 202661.45M60.21M▲ 0.76%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PLRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PLRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PLRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PLRX
PLRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.